Adaptive Prosthetic Heart Valve System with Real-time Performance Optimization

A next-generation prosthetic heart valve system that leverages advanced technologies, such as wireless control, machine learning, and artificial intelligence, to optimize valve performance in real-time, improving patient outcomes and reducing complications.

The original prosthetic heart valve patent, while providing a significant improvement over traditional open-heart surgery, still has limitations in terms of valve performance and customization to individual patient anatomy. The new inventive concept addresses these limitations by introducing adaptive stiffness, real-time performance optimization, and autonomous monitoring, enabling a more personalized and effective treatment for heart valve diseases.

The new prosthetic heart valve system comprises a stent frame with adaptive stiffness, which can be adjusted in real-time via a wireless control system. This allows for optimal valve performance based on patient-specific hemodynamic data, ensuring the best possible outcome for each individual. The system also incorporates machine learning algorithms and real-time imaging data to predict optimal implantation sites, minimizing procedural complications and ensuring optimal valve function. Furthermore, the valve is equipped with integrated sensors and artificial intelligence, enabling autonomous monitoring and adjustment of valve performance in response to changing patient conditions. This feature optimizes cardiac output and reduces the risk of complications. Additionally, the system includes a modular design with interchangeable valve components, allowing for customization of valve function and adaptation to individual patient anatomy. The valve also features a self-healing coating that can repair minor damages or defects in real-time, extending the lifespan of the valve and reducing the need for replacement or revision surgeries.

The new claims introduce a paradigm shift in prosthetic heart valve technology by incorporating advanced technologies, such as wireless control, machine learning, and artificial intelligence, to optimize valve performance in real-time. This is a significant departure from the original patent, which focused on a more traditional, mechanical approach to valve design. The new inventive concept's ability to adapt to individual patient anatomy and optimize valve performance in real-time represents a substantial improvement over existing technologies.

Alternative embodiments of the inventive concept could include variations in the stent frame design, such as using shape-memory alloys or polymers, or incorporating additional sensors or actuators to further enhance valve performance. Other variations could include different wireless control systems, such as using Bluetooth or Wi-Fi connectivity, or integrating the valve with other implantable devices, such as pacemakers or implantable cardioverter-defibrillators.

The adaptive prosthetic heart valve system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular disease treatment and heart valve replacement. The system's ability to optimize valve performance in real-time, reduce complications, and extend the lifespan of the valve makes it an attractive solution for patients and healthcare providers. The target market includes hospitals, clinics, and medical research institutions, as well as companies involved in the development and manufacturing of medical devices.